Detalhe da pesquisa
1.
Age and Chronodisruption in Mouse Heart: Effect of the NLRP3 Inflammasome and Melatonin Therapy.
Int J Mol Sci
; 23(12)2022 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35743288
2.
Retinoid-related orphan nuclear receptor alpha (RORα)-deficient mice display morphological testicular defects.
Lab Invest
; 99(12): 1835-1849, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409890
3.
Melatonin, clock genes and mitochondria in sepsis.
Cell Mol Life Sci
; 74(21): 3965-3987, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28785808
4.
Melatonin administration to wild-type mice and nontreated NLRP3 mutant mice share similar inhibition of the inflammatory response during sepsis.
J Pineal Res
; 63(1)2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28370493
5.
Melatonin Treatment Reduces Oxidative Damage and Normalizes Plasma Pro-Inflammatory Cytokines in Patients Suffering from Charcot-Marie-Tooth Neuropathy: A Pilot Study in Three Children.
Molecules
; 22(10)2017 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29036910
6.
A Successful ED Fall Risk Program Using the KINDER 1 Fall RiskAssessment Tool.
J Emerg Nurs
; 42(6): 492-497, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27160606
7.
The Impact of Melatonin Supplementation and NLRP3 Inflammasome Deletion on Age-Accompanied Cardiac Damage.
Antioxidants (Basel)
; 10(8)2021 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34439517
8.
The Impact of Melatonin and NLRP3 Inflammasome on the Expression of microRNAs in Aged Muscle.
Antioxidants (Basel)
; 10(4)2021 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33801675
9.
Melatonin alleviates sepsis-induced heart injury through activating the Nrf2 pathway and inhibiting the NLRP3 inflammasome.
Naunyn Schmiedebergs Arch Pharmacol
; 394(2): 261-277, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32936353
10.
Lack of retinoid acid receptor-related orphan receptor alpha accelerates and melatonin supplementation prevents testicular aging.
Aging (Albany NY)
; 12(13): 12648-12668, 2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32644943
11.
Melatonin/Nrf2/NLRP3 Connection in Mouse Heart Mitochondria during Aging.
Antioxidants (Basel)
; 9(12)2020 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33260800
12.
Lack of NLRP3 Inflammasome Activation Reduces Age-Dependent Sarcopenia and Mitochondrial Dysfunction, Favoring the Prophylactic Effect of Melatonin.
J Gerontol A Biol Sci Med Sci
; 74(11): 1699-1708, 2019 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30869745
13.
Involvement of plasma miRNAs, muscle miRNAs and mitochondrial miRNAs in the pathophysiology of frailty.
Exp Gerontol
; 124: 110637, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31199979
14.
The Protective Effect of Melatonin Against Age-Associated, Sarcopenia-Dependent Tubular Aggregate Formation, Lactate Depletion, and Mitochondrial Changes.
J Gerontol A Biol Sci Med Sci
; 73(10): 1330-1338, 2018 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29562315
15.
Analysis of Plasma MicroRNAs as Predictors and Biomarkers of Aging and Frailty in Humans.
Oxid Med Cell Longev
; 2018: 7671850, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30116492
16.
In Vivo Determination of Mitochondrial Respiration in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Zebrafish Reveals the Efficacy of Melatonin in Restoring Mitochondrial Normalcy.
Zebrafish
; 15(1): 15-26, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29185873
17.
Contribution of inducible and neuronal nitric oxide synthases to mitochondrial damage and melatonin rescue in LPS-treated mice.
J Physiol Biochem
; 73(2): 235-244, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28110436
18.
The benefit of a supplement with the antioxidant melatonin on redox status and muscle damage in resistance-trained athletes.
Appl Physiol Nutr Metab
; 42(7): 700-707, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28192673
19.
Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases.
PLoS One
; 12(8): e0183090, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28800639
20.
Palivizumab prophylaxis of respiratory syncytial virus disease in 2000-2001: results from The Palivizumab Outcomes Registry.
Pediatr Pulmonol
; 35(6): 484-9, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12746948